Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Subpotent drug
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
LABELING: LABEL MIX-UP
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
Acidified product is recalled due to lack production record.
Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.
CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.